Quantitative oncogene-mapping within malignant tumors through Multi-parameter MRI based on RNA-triggered nanoprobes. [PDF]
Li W +8 more
europepmc +1 more source
Tumor-targeted aptamer-conjugated engineered bacteria for CXCL9 cytokine delivery in non-small cell lung cancer immunotherapy. [PDF]
Gu Q +7 more
europepmc +1 more source
Aptamer-liposome targeted nanotherapeutics for cancer therapy: Bibliometric analysis, recent developments and future perspectives. [PDF]
Gao Z +8 more
europepmc +1 more source
Human Serum Albumin as a Prodrug Carrier for Tumor Therapy: Mechanisms, Applications, and Future Perspectives. [PDF]
Shang Y +5 more
europepmc +1 more source
Dual Aptamers-Based SETDB1 PROTACs as Effective Anti-Tumor Strategies for Breast Cancer. [PDF]
Guo Y +6 more
europepmc +1 more source
Enhancing the intracellular delivery of antisense oligonucleotides (ASO) : a comparative study of aptamer, vitamin E, and cholesterol ASO conjugates. [PDF]
Balachandran AA +4 more
europepmc +1 more source
Aptamers and aptamer-drug conjugates as synthetic immune modulators for cancer immunotherapy. [PDF]
Arshad F +6 more
europepmc +1 more source
DNA Nanotechnology-Enabled Precise Regulation of Nanozymes and Their Applications. [PDF]
Liu Z +11 more
europepmc +1 more source
Synthetic short RNA in cancer. [PDF]
Tomita T, Minagawa K, Hiratsuka S.
europepmc +1 more source
Rational redesign of high-activity G-quadruplex DNAzyme through flanking and looping of nucleobases. [PDF]
Adeoye RI +4 more
europepmc +1 more source

